Moreover, in the hope of effective development of NmAbs based cocktails, a combination with repositioned antiviral drugs is an attractive treatment mean, as the combination of these later with CP led to satisfactory results in treating COVID-19 patients. This evidence concerns the gene CP and COVID-19.